Palisade Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-667	Closed	-$336K	–	423
2019 Q1	$336K	Sell	667 -150	-18%	-$75.6K	0.01%	386
2018 Q4	$403K	Buy	817 +84	+11%	+$41.4K	0.01%	388
2018 Q3	$671K	Buy	+733	New	+$671K	0.02%	380